3 completed. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Kuvan®: new trials by email Literature Review of Kuvan® trials Research Report on Kuvan®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Open-label Study to Evaluate the Response and Safety of Kuvan® in Subjects With Phenylketonuria Kuvan® - Phenylketonuria | Phase 3 | Completed | Merck KGaA, Darmstadt, Germany | 90 | 2012-11-01 | 2014-07-28 |
| Kuvan® in Phenylketonuria Patients Less Than 4 Years Old Kuvan®, Phenylalanine (Phe)-restricted diet - Phenylketonuria | Phase 3 | Completed | BioMarin Pharmaceutical | 56 | 2011-06-01 | 2017-09-15 |
| Open-Label Extension Study of Kuvan for Autism Kuvan® - Autistic Disorder | Phase 2 / Phase 3 | Completed | The Children's Health Council | 41 | 2009-08-01 | 2018-05-02 |
Phenylketonurias (2) · Autistic Disorder (1) · Genetic Diseases, Inborn (1)
BioMarin Pharmaceutical (1) · Merck KGaA, Darmstadt, Germany (1) · The Children's Health Council (1)
Germany (2) · Austria (1) · Belgium (1) · Czechia (1) · Italy (1) · Netherlands (1) · Slovakia (1) · Turkey (Türkiye) (1) · United Kingdom (1) · United States (1)
Glen R Elliott, PhD, MD (1) · Ignacio Alvarez, MD (1)
2009 (1)